Camilo Acero joined Ontario Genomics in 2014. He oversees the organization’s digital communications and graphic design, and is responsible for its visual identity and brand standards. He built Ontario Genomics’ in-house design capability and now designs and produces all of its internal and external communications materials, along with the tools that keep the brand consistent across programs, initiatives and events.

He has played a key role in the development and management of Ontario Genomics’ digital presence, including its website, microsites, digital campaigns and social media, strengthening stakeholder engagement and program delivery. His work includes creating brand identities and producing communications collateral for major programs such as BioCreate, BioScale, Harvest and wasteCANcreate. He designs and lays out the organization’s strategic reports, which support genomics-based innovation and funding opportunities across multiple sectors. He has also contributed to events that foster collaboration, knowledge sharing and industry connections, including SynBio, Genomics in the Park and program information sessions.

Camilo holds a bachelor’s degree in advertising and has worked in communications and marketing for more than twenty years, across the corporate and not-for-profit sectors in the United States and Canada.

Jacqueline Binnick joined Ontario Genomics in 2026 as their People and Culture Specialist. Born and raised in Toronto, she pursued her Bachelor degree at the University of Toronto and went on to George Brown to study Human Resources Management. Prior to her role, Jacqueline spent a decade in the Toronto Public Library system. During this time, she discovered her love of serving Toronto’s vibrant and diverse communities which ultimately led her to Ontario Genomics, where she can support and champion a dynamic team working to improve the quality of life and future for all Ontarians. Jacqueline is passionate about fostering inclusive workplace cultures where people feel valued, connected, and inspired to do their best work.

Dr. Elaine Corbett is the Senior Director of Business Development & Philanthropy at Ontario Genomics. Elaine brings more than two decades of progressive leadership experience spanning industry, non-profit, and academia. In her current role, she leads efforts to expand partnerships, unlock new revenue streams, and drive sponsorship, investment, and philanthropic opportunities, mobilizing government, industry, investor, and philanthropic partners to support mission-driven initiatives that help innovators bring game-changing solutions to market.

Elaine has led initiatives across food and agriculture, cleantech, health, and biomanufacturing, securing millions in funding, building strategic partnerships, and advancing programs that drive innovation, commercialization, and economic growth.

Prior to joining Ontario Genomics in 2014, Elaine held leadership and scientific roles at two Canadian medical device and biotechnology companies. At SQI Diagnostics, she managed multidisciplinary programs advancing microarray diagnostics, leading to successful regulatory submissions and product launches. At Axela, she led client engagement, collaborated with cross-functional teams on product and platform development, and supported sales and commercialization efforts across diagnostic technologies.

Elaine received her Honours BSc in Biomedical Science from University College Cork, Ireland. She earned her PhD in Biochemistry from the University of Alberta, where her research focused on the endoplasmic reticulum and the chaperones involved in protein folding. She subsequently completed a postdoctoral fellowship at The Hospital for Sick Children in Toronto, where her work focused on cell-mediated immunity and phagocytosis. Elaine received numerous academic awards and scholarships, including support from CIHR, AHFMR, the Heart & Stroke Foundation, the Wellcome Trust, and others, and was awarded a Gold Medal for academic achievement during her undergraduate studies.

Dr. Mike Dorrington joined Ontario Genomics in 2020. In his current role, Mike drives our Food and Industrial Biotechnology strategies, building and overseeing targeted programming, acting as an ecosystem convenor, and evaluating market needs. This work includes acting as lead for the HARVEST Agri-Tech Accelerator, wasteCANcreate Upcycling Consortium, and our training and talent development work. Before joining Ontario Genomics, Mike was a post-doctoral fellow in the Laboratory of Immune System Biology at the National Institute of Allergy & Infectious Diseases. In this position, he studied the many roles of antiviral cytokines in inflammation and antibacterial immune responses using cutting-edge genomic and transcriptomic technologies.

Mike has a Ph.D. in Infection & Immunity from McMaster University and a B.Sc. in Life Sciences from the University of British Columbia.

Dr. Elizabeth Gray joined Ontario Genomics in 2023. In her current role, she provides leadership to a funding initiative aimed at supporting SMEs in health, cleantech and agri-food sectors seeking to commercialize genomics and engineering biology research and technologies, ultimately bringing innovative solutions to the Canadian and International markets.

Elizabeth brings 15 years of progressive leadership experience in direct commercialization to this role, having worked in both the public and private sectors. Prior to joining Ontario Genomics, Elizabeth was a VP at a healthcare investment firm, DRI Capital. She also held progressive leadership positions at Eli Lilly Canada, working in both the commercial and medical divisions. Notably, Elizabeth was the Medical Director, Neuroscience, where she built the medical team and launched products in the neuroscience portfolio, from regulatory submissions, to product launches, clinical studies and post launch activities. Elizabeth also worked at CCRM (Center for Commercialization of Regenerative Medicine) and CAMH (Center for Addiction and Mental Health), where she evaluated early-stage technologies for their commercialization potential, managed a large portfolio of patents, completed successful licensing deals, and liaised with corporate partners for licensing deals.

She received her PhD from the University of Toronto, Department of Molecular Genetics and focused on neuronal cell signaling. Her MSc is from McGill University, Department of Plant Science and focused on plant- microbial signaling, whereby she discovered a novel bacteriocin.